Literature DB >> 8159257

Increased accumulation of cAMP in cerebral microvessels in Alzheimer's disease.

P Grammas1, A E Roher, M J Ball.   

Abstract

The objective of this study was to compare the adenylyl cyclase-cAMP second messenger system in cerebral microvessels isolated from Alzheimer's patients to that in microvessels from nondemented elderly controls. To evaluate the role of aging separate from the effects of dementia, microvessels from young and aged rodents were also examined. The results of this study indicated that microvessels isolated from autopsy material can be used to evaluate adenylyl cyclase activity. The data showed that cAMP levels, as an index of adenylyl cyclase activity, are significantly (p < 0.02) elevated in microvessels from Alzheimer's disease compared to nondemented elderly controls. Stimulation of adenylyl cyclase by forskolin was comparable in both groups of microvessels. A comparison of unstimulated microvessels from young and aged rodents yielded no significant difference in cAMP levels. These results indicate an increased level of cAMP in the microvessels of Alzheimer's patients with no age-related change demonstrable in rat microvessels.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8159257     DOI: 10.1016/0197-4580(94)90151-1

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  5 in total

Review 1.  Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain.

Authors:  Michy P Kelly
Journal:  Cell Signal       Date:  2017-11-23       Impact factor: 4.315

2.  Cerebrovascular transforming growth factor-beta contributes to inflammation in the Alzheimer's disease brain.

Authors:  Paula Grammas; Roma Ovase
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

3.  Microvessels from Alzheimer's disease brains kill neurons in vitro.

Authors:  P Grammas; P Moore; P H Weigel
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

Review 4.  Phosphodiesterase Inhibitors for Alzheimer's Disease: A Systematic Review of Clinical Trials and Epidemiology with a Mechanistic Rationale.

Authors:  Owen Sanders; Lekshmy Rajagopal
Journal:  J Alzheimers Dis Rep       Date:  2020-06-16

5.  Prediction of hub genes of Alzheimer's disease using a protein interaction network and functional enrichment analysis.

Authors:  Jia Jin Wee; Suresh Kumar
Journal:  Genomics Inform       Date:  2020-12-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.